The peptide grey market collapsed in 9 months. Quality got dramatically better.
An 8× drop in the sub-95% purity fail rate over 14 months. The market shrank and the product got cleaner at the same time.
TitrateLab
Every grey-market vendor, measured against the third-party lab record. Tested purity, delivered dose, the batches that fail — evidence, not the seller’s word.
Every third-party certificate of analysis we can find — parsed, normalized, and titrated to its real purity. Here's the whole market in one curve: the molecule is usually clean; the tail is where it fails.
We check what the label claims against what the assay actually measured. The peptide itself tests near-pure — where it breaks is the fill.
Every vendor carries a letter grade computed from the lab record — never marketing, never vibes.
Tail-gate: one failing batch floors the letter — a 468-cert vendor sits at C behind cleaner, smaller ones. Volume can't buy an A. The worst evidence sets the ceiling.
How we grade the letter →One domain-trained analyst sits behind every number on this page. Titer looks up the research, reads it against the live database, and grades what he tells you against the trials. The next two chapters put him to work: he plans the cycle, then runs the order.
PubMed, ClinicalTrials, and EuropePMC, indexed.
861 vendors graded A–F, plus live vendor prices.
Fabricated citations stripped before they reach you.
Quotes it, builds the cart, settles on-chain.
Auto-pulled from PubMed and ClinicalTrials.gov every 30 minutes. Three picks worth your attention right now, plus one weird one in the margin — every claim links back to the source.
Tell Titer your goal; it proposes compounds, doses, and a schedule — reconstitution math down to the units on a U-100 pen, a drug-interaction check before you save, and a dosing calendar you subscribe to.
Message it on Discord, the web, or Telegram. The concierge reads it, compares live prices against the lab record — never invented — builds the cart, and settles payment. Bitcoin verifies on-chain, automatically.
One order ledger across every channel — turn any cycle into a sourced order, matched on price + lab evidence.
Start free →vendors buried by their own lab record.
The record outlives the storefront. When the lab evidence turns, the money and the vendor both disappear. We keep the receipts so the next buyer doesn't inherit the loss.
Walk the graveyard — 33 documented →Grade movements, fresh certs, new underfill flags — a free weekly readout of who got better and who slipped. No account required.
The assayed peptide content, cert by cert — median, spread, and every outlier batch.
What's actually in the vial vs. the label claim. Catch the underfill before you reconstitute.
Independent LAL results surfaced where labs report them — the number nobody markets.
The data behind every claim on this page is public. Open any of it — no card, no signup.
The platform is open and the research is live today — sourced, dated, and updated as the data changes.
An 8× drop in the sub-95% purity fail rate over 14 months. The market shrank and the product got cleaner at the same time.
The most-discussed hormone on the market is the one almost nobody verifies — the widest gap between chatter and third-party testing of any compound we track.
Whether BPC-157, TB-500, and ~12 other peptides return to Category 1 — decided at the FDA advisory committee vote on July 23, 2026.
Every shutdown, exit scam, and FDA action on the record — primary sources only. The canonical “what happened to that vendor” reference.
Ask our research assistant anything about peptides, vendors, or the data we track. Every answer cites back to the specific COA batch, article, or vendor incident it came from.
Not medical advice · how the bot knows what it knows
Anonymous, no account, no email. We OCR it, parse it, and add it to the corpus that powers vendor pages and trust grades. Real lab COAs always outweigh user submissions in the math — but the long tail only gets covered if customers like you drop one in.
Lifetime: $33 one-time — same Pro, forever.
It is live now. You can read the full research corpus and use the free tier with no account and no card, and orders route through the site today. Any 'once this launches' wording you spot is stale copy from before launch.
The fee is 8% of the pre-shipping order subtotal, charged only when you place an order, with no markup on the peptide itself. It pays for OEM selection, verifying the batch against the COA archive before routing, cross-checking that the batch you receive matches what you paid for, shipping orchestration, and dispute mediation if a batch comes back off.
No. There is no pay-to-rank, no affiliate links, and no sponsored placements - a vendor cannot buy a better number. Grades are computed from Finnrick and Janoshik lab data plus community-submitted COAs.
The rankings sit on 60,349 third-party COAs across 4,051 manufacturers, drawn from Finnrick, Janoshik Analytical, and community submissions over a 19-month window, and TitrateLab names the lab on each individual record. It is measurement that is cited and dated, not aggregated hearsay.
The corpora ingest continuously, the public counts refresh daily, and vendor scores recompute on each new COA and re-validate nightly. The site also lists 27 dated vendor shutdowns rather than letting a dead vendor keep a stale grade.
A letter grade is a cert-count-weighted proxy, not a guarantee of quality on any single order, and a high grade can still hide an underfilled batch. It tells you how much independent testing exists and how that testing landed against label, where 'in spec' means purity at or above 90 percent and the labeled dose filled within about 10 percent where dose data exists.
Free with no signup: the live alerts ticker, the bottom-10 hall of shame, the vendor graveyard, research picks pulled from PubMed and ClinicalTrials.gov, the chat bot, and all five research articles. Pro ($9/mo) adds the full manufacturer leaderboard, custom watchlists with email alerts, and the full historical alerts archive, plus an AI assistant; read-only API access and early research drops are listed as coming in Q3 2026.
Pro is $9 a month, cancel anytime ($3/mo of AI-assistant usage included) — or $33 one-time for lifetime access. There is also an earned path: route $1,000 of verified orders through the site and Pro becomes permanent at no charge.
Everything is framed research-use-only: the site footer reads 'For research use only. Not for human consumption,' and the vendors who ship label their product the same way. TitrateLab does not stock or sell the peptides - it routes your order to a vendor for an 8% flat fee with no markup, so what arrives ships from that vendor, not from us. We do not give legal or medical advice; this is a data desk, not counsel, so take legal questions to a qualified source.
It is real. The site publishes data and explicitly does not give medical advice or counsel personal use - that is stated as out of scope on the pricing page. The assistant is there for questions about the corpus and vendors, not personal-use protocols.
Orders on the site are paid in Bitcoin. A Bitcoin payment is not reversible by the network, but the 8% fee includes incident dispute mediation that can broker a rework or refund if a batch comes back off. No specific refund window is published.
Before routing, the batch is verified against the COA archive and cross-checked so what you get matches what you paid for. If it still comes back off, the fee covers dispute mediation that brokers a rework or refund with the OEM. Product warranties sit with the OEM, not TitrateLab.
Essential cookies keep the site working and optional analytics cookies can be declined; neither category shares personal data with third parties. COA contributions are anonymous with no account and no email, and no per-user Discord data, username, or ID is exposed in any published figure.